Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 853 of 1,261
  1. US 8530405

    Method of preparing water-soluble and biodegradable antimicrobial agent

    FAR EASTERN NEW CENTURY CORPORATION · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  2. US 8530663

    1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds

    Theravance, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  3. US 8529898

    Activatable binding polypeptides and methods of identification and use thereof

    The Regents of the University of California · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  4. US 8529882

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  5. US 8529885

    AAV vectors for in vivo gene therapy of rheumatoid arthritis

    ACADEMISCH MEDISCH CENTRUM · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  6. US 8529907

    Methods of treating ophthalmic disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  7. US 8530245

    Methods and compositions related to acetylocholine receptor conjugates

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  8. US 8530167

    Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  9. US 8530499

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  10. US 8530466

    Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis

    Rigel Pharmaceuticals, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  11. US 8530492

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  12. US 8530621

    Combined preparation of a thiazide diuretic and a loop diuretic

    The Regents of the University of California · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  13. US 8530675

    Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (rose bengal) and related xanthenes

    Provectus Pharmaceuticals, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  14. US 8529916

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  15. US 8529257

    Aerosolized ceramic porcelains and glaze composition

    EnameLite, LLC · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  16. AU 2013203283

    Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyophenyl)-2-methanesulfonylethylamine

    CELGENE CORP [CH] · Granted Sep 5, 2013 · Expires Aug 31, 2033

    granted
  17. US 8524214

    Polyal drug conjugates comprising variable rate-releasing linkers

    Mersana Therapeutics, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  18. US 8524901

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  19. US 8524902

    [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  20. US 8524906

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  21. US 8524910

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  22. US 8524908

    Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one

    Almirall, S.A. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  23. US 8524767

    Modulators of ATP binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  24. US 8524674

    Method of improving the conditioned reflex habit, the muscle tonus, or the motion coordination of a patient after suffering trauma to the brain cortex

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.